FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Everything You Need to Know About the FDA Peptide Ban